Quick ReadPlain-language overview · read this first
Nata Opto-electronic is a domestic semiconductor-materials company producing precursors / MO sources, electronic specialty gases, and ArF photoresist; current price about RMB 56, market cap about RMB 38.7 billion, rated Watch.
2025 revenue was RMB 2.585 billion, net profit attributable to the parent RMB 320 million, and operating cash flow RMB 733 million, continuously above accounting profit; precursor gross margin 50.37%, specialty gas gross margin 35.30%, MO sources are the real moat anchor. But specialty gas gross margin fell 11.21 percentage points year-on-year in H1 2025, and ArF photoresist 2025 revenue was only RMB 20 million, so both pricing power and ramp speed are shaky. Comparable Yoke Technology, at PE 54.8x and PB 6.8x, is actually cheaper; 2025 asset impairment was RMB 160 million and goodwill fell 71.9%.
DCF fair intrinsic value RMB 16-25, a 124%-250% premium at the current price; ideal buy zone RMB 15-20 per share. If the valuation compresses from above 100x back to 40-60x, a permanent drawdown of 40%-60%, so the current price has already overdrawn distant assumptions.
LeadNata Opto-electronic has genuine capabilities in semiconductor materials such as precursors, electronic specialty gases, and ArF photoresist, with acceptable cash-flow quality; but a static PE of roughly 121x and PB of about 11x already price in years of distant growth, leaving no margin of safety, rated Watch.
Prices in the article are as of publication; see the valuation band above for the live price.
Conclusion First
If I examine Nata Opto-electronic as a business I intend to hold for the long term—one I would even be willing to "acquire outright"—my preliminary conclusion is: the company itself is worth serious study, but at its current price the margin of safety is insufficient, and a new long-term purchase is not worthwhile. My rating is "Watch". The company has genuine technical accumulation in key semiconductor materials such as advanced precursors, electronic specialty gases, and ArF photoresist, and its operating cash flow is clearly stronger than its accounting profit; but its business quality is not good enough to ignore valuation, especially given that the electronic specialty gas business is under gross-margin pressure, photoresist revenue is still small in scale, and profit still contains a certain amount of subsidies and investment income—while the market has already assigned a very high valuation. For an investor who is balanced-to-conservative with a holding period of 10 years or more, this now looks more like a combination of "good story + strong industrial position + excessive price" than "good company + good price".
Based on the market-quote pages retrievable in recent days, Nata Opto-electronic's web quote in mid-May 2026 roughly fell between RMB 54.67 and RMB 56.54 per share; given cache differences across web pages, this report adopts RMB 56 per share as an approximate current price. Based on total share capital of 691 million shares at the end of 2025, this corresponds to a market cap of about RMB 38.7 billion; based on 2025 net profit attributable to the parent of RMB 320 million, the static PE is about 121x; based on 2025 net assets attributable to the parent of RMB 3.482 billion, the PB is about 11.1x. In value-investing terms, this has essentially already priced in fairly optimistic growth expectations for the coming years.
Brief Conclusion Table
| Item | Assessment |
|---|---|
| Investment rating | Watch |
| Core judgment | The business is understandable, and the key-material attributes are real; the company has certain technical and customer-validation barriers; cash-flow quality is acceptable; but the current valuation is unfriendly to conservative long-term investors |
| Does the current price offer a margin of safety | No |
| Suitable investor type | Better suited to growth investors, industry-trend investors, and research-oriented semiconductor-material investors willing to bear high-valuation volatility; less suitable for ordinary long-term value investors |
| Biggest uncertainty | The pace of ArF photoresist commercialization; whether electronic specialty gas margins can hold; whether the current high valuation can be delivered by future results |
To avoid "treating inference as fact", the text below tries as far as possible to distinguish caliber. Anything based on announcements, annual reports, audit reports, or investor-relations materials I mark as Fact; any valuation assumption or competitive judgment built on these facts I explicitly write as Assumption or Inference; the final rating is an Opinion.
Data Boundaries and Limitations Three points need to be stated up front. First, real-time stock-price pages have cache differences, so the "current price" adopts the approximate value of RMB 56 per share. Second, this report did not directly obtain the full-year capex details from the body of the complete 2025 audit report, so Owner Earnings uses a conservative maintenance-capex assumption. Third, the concentration of the top five customers/suppliers is insufficient in the original source fragments directly retrievable this time, so the related judgment is stated cautiously as "no obvious dependence on a single large customer" rather than asserted outright.
Business, Industry, and Moat
Understanding the Business
Fact: Nata Opto-electronic currently focuses on three core electronic-material segments: advanced precursor materials (including MO sources), electronic specialty gases, and photoresist and supporting materials. In its 2025 annual report summary, the company explicitly states that these products are mainly used in manufacturing links such as integrated circuits, flat-panel displays, LEDs, third-generation semiconductors, photovoltaics, and semiconductor lasers. The company also discloses that it is one of the world's major MO source manufacturers, with product purity reaching 6N and above, able to provide a full MO source range with supporting and customized services; on electronic specialty gases, the company says its fluorine-based gas capacity and quality lead domestically; on photoresist, the company emphasizes that its in-house capability spanning functional monomers, functional resins, photosensitizers, and finished photoresist products and supporting materials is taking shape.
This business is not mysterious. In essence it is: supplying high-purity, stable, verifiable, and continuously deliverable key electronic materials to wafer fabs / display-panel makers / LED makers. What customers buy is not "the chemical itself" but "stable yield + supply security + sustained delivery capability after passing validation". The charging model is simple—product sales; but what truly determines profit quality is not the ex-factory price per ton, but whether the products have passed customer validation, whether they can move into higher value-added categories, and whether they can go from "able to supply" to "stable large-volume supply". This is what makes Nata Opto-electronic closer to an "industrial technical-materials company" than an ordinary chemical company, and it explains why it can command a valuation higher than traditional chemicals.
In terms of revenue stability, this is not a highly repeating, high-brand-stickiness cash cow like consumer goods, but nor is it a one-off project-type business. Once it enters a customer's volume-production line, the material is continuously consumed as wafer and display-panel output rises, giving it a degree of repeat-purchase character. In the first half of 2025 the company's direct-sales proportion reached 90.48%, showing that it primarily faces end industrial customers directly rather than relying on layered distribution; over the same period, precursor materials (including MO sources) generated RMB 342 million in revenue at a 50.37% gross margin, and specialty gas products generated RMB 749 million in revenue at a 35.30% gross margin, showing that the company has formed a business mix of "high-margin precursors + medium-margin specialty gases + early-stage photoresist".
In terms of cost structure, Nata Opto-electronic remains a business driven by both manufacturing and R&D. In 2025 the company's operating costs were RMB 1.561 billion, corresponding to a blended gross margin of about 39.6%; in the same year R&D expense was RMB 207 million, with R&D investment accounting for 8.02% of operating revenue. This means it is not an "asset-light, R&D-free" asset, but one that must continuously invest in process, validation, talent, and safety/environmental systems to maintain its competitive position. In other words, its distributable cash flow is real, but one cannot treat all operating cash flow as perpetual free cash.
If the stock market were closed for five years, would I be willing to hold this business? If the purchase price were low enough, I would hold it on a research basis; at the current price, I would not. The reason is not that the business is hard to understand, but that it still carries clear growth-stock characteristics: it needs continuous R&D, customer validation, and new-product ramp, and some segments' margins are very sensitive to competition and price. For a long-term business owner, the business is understandable, but the "acquisition price" is not right.
Business-understandability score: 4/5.
Industry and Competitive Landscape
The big-picture industry direction is still a growth industry. According to SEMI, the global semiconductor materials market was $67.5 billion in 2024, up 3.8% year-on-year; according to SIA and WSTS, global semiconductor sales in 2025 were about $791.7 billion, up 25.6% year-on-year, and industry sales in 2026 are expected to approach $975 billion. This shows that downstream demand is not weak over the long term, especially under the pull of AI, advanced memory, and logic chips, where the long-term trend of material demand still points upward.
But there is a very important value-investing distinction here: "semiconductors are a good industry" does not mean "every semiconductor-materials company is a good business". Although the materials industry benefits from industrial upgrading and domestic substitution, it also has clear technology iteration, certification cycles, capacity-expansion volatility, price competition, and policy disturbances. In its 2025 investor-relations activities the company itself admitted that the 2024 revenue growth was mainly driven by precursors and electronic specialty gases, while the average product gross margin fell year-on-year, mainly because some product prices declined slightly. In the first half of 2025, the gross margin of specialty gas products fell another 11.21 percentage points year-on-year. This shows that although the industry is good, it does not inherently possess strong pricing power.
On the competitive landscape, Nata Opto-electronic faces not a single rival but "competition across separate tracks". In precursors / MO sources it competes with electronic-materials companies such as Yoke Technology; in specialty gases it is more comparable to companies such as Huate Gas; in photoresist and supporting materials it faces stronger or more mature rivals such as Jingrui Electronic Materials, Tongcheng New Materials, and Shanghai Sinyang. Nata Opto-electronic's advantage is its relatively complete horizontal layout—it is not a single-material company; but its disadvantage is that, apart from a few categories, it is not the absolute leader in many sub-links. More critically, the photoresist business is still small today. On an interactive platform the company stated that in 2025 ArF photoresist revenue exceeded RMB 20 million, with 6 products having passed customer validation and generating sales, though not yet at full capacity. This proves the direction is correct, but the scale is still far from "large enough to re-rate the company's entire profit center of gravity".
Therefore, my judgment on the industry is: this is a "mid-to-upstream technical-materials company within a good industry", not a bad industry in the traditional sense, but nor is it the kind of moat industry where you effortlessly rake in profits. Its long-term demand is fairly stable, but technology and price competition coexist; the industry's profit pool is not evenly distributed but concentrates toward the few companies with sufficient validation, deeper product matrices, and stronger customer binding.
Industry-attractiveness score: 3/5.
Moat Analysis
Nata Opto-electronic's most genuine moat is not brand or network effect, but process accumulation + customer validation + high-purity stable-supply capability. This kind of moat is not always conspicuous on the financial statements, but it is crucial in the materials industry. The company discloses that in the synthesis and preparation, purification, analytical testing, and packaging containers of MO sources it has reached internationally advanced levels; as of the first half of 2025, the company and its main subsidiaries held 363 proprietary patents, including 193 invention patents, and have undertaken national projects such as the 863 Program and the 02 Major Special Project. By the end of 2025, media excerpts of the annual report show the patent count had risen to 380, of which 205 were invention patents. These all support its "not-easily-and-immediately replicable" capability in several high-end material categories.
But moat strength must be viewed segment by segment. On MO sources / advanced precursors, the moat is relatively strongest. The reason lies in purity, stability, supporting capability, and validation cycles. On electronic specialty gases, the moat is somewhat weaker, relying more on scale, supply stability, and customer onboarding, with price competition more evident. On ArF photoresist, the moat can in theory be very strong, but in reality it is still forming, because the revenue scale is currently too small and commercialization has just begun.
On whether "the moat is widening, stable, or narrowing", my judgment is: overall stable to slightly widening, but not significantly widening. The evidence for widening is that the company's R&D platform, product matrix, number of customer validations, and patent reserves are increasing, and ArF photoresist is advancing from "R&D" toward "validation + orders"; the evidence for insufficient width is that both 2024 and the first half of 2025 saw price or gross-margin pressure, especially in the specialty gas segment. A truly very wide moat should be able to pass on inflation and competition more stably; whereas Nata Opto-electronic currently has bargaining power mostly in certain high-end categories and has not yet fully established it at the overall level.
If asked about the difficulty of a competitor replicating it, my Inference is: replicating a single product may not take extremely long, but replicating "multi-category layout + validation record + volume-production stability + safety/environmental systems + customer-side trust" would take at least several years and from several hundred million to over a billion RMB of capital investment, especially when precursors, specialty gases, and high-end photoresist are laid out simultaneously. This judgment comes not from a single announcement but from the company's continuous disclosures about its technical system, in-house platform, validation progress, and product matrix.
On macro resilience, the company has some toughness but is not strongly defensive. Among the four quarters of 2025, fourth-quarter net profit attributable to the parent was only RMB 18.97 million, a clear pullback from the first three quarters; however, in the first quarter of 2026 it recovered to RMB 124 million. This shows the company can stay profitable, but profit volatility is not small. In an economic downturn or a contraction in industry capex, it is not as stable as consumer staples, but more like an industrial-materials growth stock that "swings widely in boom times and whose valuation also retreats quickly in downturns".
Moat-strength score: 3/5.
Management and Capital Allocation
Is Management Trustworthy
My assessment of management is: overall rational, not quite an "outstanding capital allocator", but at least more credible than aggressive management. Three types of facts support this. First, the company's annual reports in recent years have all received a standard unqualified audit opinion, and the 2025 internal-control evaluation found no material weaknesses. Second, the company has not doggedly pushed every project to the end: the 2025 interim report explicitly disclosed that, due to intensifying market competition, the large subsequent R&D and equipment investment required, and rising risk that economic returns would fall short of expectations, the company terminated the "hexafluorobutadiene industrialization project" and sold the related assets to Shandong Qixin Gas Co., Ltd. for a consideration of RMB 69.03 million. Such behavior of "acknowledging a change in project economics and cutting losses in time" is more commendable than blindly spinning a story. Third, in 2025 the company continued to advance reforms in sales, procurement, R&D, and digitalization, showing that management does not rely solely on the industry's tailwind but is genuinely optimizing its operating organization.
But management is not without problems. In 2025 the company recognized RMB 160 million in asset-impairment losses, up about 26% year-on-year, and its goodwill balance fell about 71.9% year-on-year, reflecting that some past investment / asset allocation was not entirely successful. In value-investing terms, this cannot be directly equated with fraud; on the contrary it shows the company owned up to the problems in its accounting. But it also reminds us: this is not a company where "every capital allocation is extremely precise".
Shareholder Alignment and Capital Use
From the ownership structure, Nata Opto-electronic is not a company with a strong actual controller. The 2025 interim report disclosed that Shen Jie and Beijing Hongyu Rongji are acting in concert, holding 11.70% in aggregate; the same report also emphasizes that the company is a listed company without an actual controller. The benefit of this structure is relative dispersion—no single large shareholder can arbitrarily extract benefits; the drawback is that governance relies more heavily on the long-termism of the board and professional managers. On management shareholding, director Zhang Xingguo held 43.0878 million shares as of the first half of 2025, and president Wang Luping held 780,000 shares, showing it is not entirely "zero shareholding", but also not extremely deep binding.
On capital use, in recent years the company has mainly done four things: reinvestment, acquisition of minority interests, cash dividends, and a small amount of equity incentives. The company successively acquired the minority stake in Zibo Nata for RMB 272.86 million in 2023, and 16.5398% of Quanjiao Nata for RMB 229.8 million in 2025, continuing to bring the cash flow and control of key subsidiaries back into the listed platform. In accounting terms, this also caused long-term payables to rise clearly at the end of 2025, with the official explanation being "an increase in unpaid consideration for acquiring subsidiary minority interests". Such transactions are strategically coherent, because the entire profit of high-quality material subsidiaries can be more concentrated into the listed company; but the cost is that one must continuously verify whether the acquisition price is reasonable and whether the targets can truly deliver on their commitments.
On dividends, management has clearly increased shareholder returns over the past two years. The 2025 interim report states that cumulative cash dividends for fiscal 2024 (including interim and annual) reached RMB 84.7547 million, with a payout ratio of 31.28%; the same report also disclosed that the company planned to distribute RMB 1.80 per 10 shares for the first half of 2025; the 2025 annual report summary disclosed that the company planned to distribute RMB 2.80 per 10 shares of 2025 profit. This shows the company is not blindly pursuing scale expansion and is beginning to place more emphasis on shareholder returns. For conservative investors, this is a plus.
On buybacks, there is no evidence that the company conducted meaningful open-market repurchases. What can currently be retrieved is that in 2024 it repurchased and cancelled 260,000 restricted shares due to reasons such as the departure of equity-incentive recipients, for funds of about RMB 2.9198 million—this looks more like supporting equity incentives than actively using undervaluation to buy back. In other words, the company relies mainly on dividends for capital returns rather than opportunistic buybacks.
On equity incentives, the company implemented equity incentives for a controlled subsidiary in 2023, aiming to bind the operating team and core backbone; in the first half of 2025 share-based payment expense was about RMB 7.5776 million. I tend to view it as an arrangement that is "acceptable, but where dilution and vesting conditions must be watched". As long as the incentives revolve around ROIC, profit quality, and operating cash flow rather than pure revenue expansion, this approach is not a bad thing.
Management and capital-allocation score: 3/5.
Financial Quality and Owner Earnings
Key Financial Review
Below is first a table that aims for "fewer conclusions, more data". Because the full 2025 capex details were not completely obtained from the original fragments directly retrievable this time, the table lists capex only with the official 2022-2024 figures, and the 2025 Owner Earnings is estimated separately later.
| Year | Revenue | Net profit (parent) | Net operating cash flow | Net margin | OCF / net profit | Weighted ROE | Capex |
|---|---|---|---|---|---|---|---|
| 2020 | RMB 595 million | RMB 87 million | RMB 128 million | 14.6% | 1.47x | 6.90% | Data to be supplemented |
| 2021 | RMB 984 million | RMB 136 million | RMB 262 million | 13.8% | 1.92x | 8.75% | Data to be supplemented |
| 2022 | RMB 1.581 billion | RMB 187 million | RMB 229 million | 11.8% | 1.23x | 9.30% | RMB 534 million |
| 2023 | RMB 1.703 billion | RMB 211 million | RMB 529 million | 12.4% | 2.50x | 9.59% | RMB 170 million |
| 2024 | RMB 2.352 billion | RMB 271 million | RMB 627 million | 11.5% | 2.32x | 13.42% | RMB 202 million |
| 2025 | RMB 2.585 billion | RMB 320 million | RMB 733 million | 12.4% | 2.29x | 9.19% | Data to be supplemented |
The 2020-2023 data in the table mainly come from the 2022, 2023, and 2024 annual report summaries; the 2024 data come from the 2024 audit report / 2024 annual report summary; the 2025 data come from the 2025 annual report summary and the 2025 financial statement report. The 2022-2024 capex figures come respectively from the cash-flow statements in the 2023 annual report and the 2024 audit report.
Looking at this table alone, three things matter.
First, revenue and profit growth over the past six years is real. From 2020 to 2025, revenue grew from RMB 595 million to RMB 2.585 billion, and net profit attributable to the parent grew from RMB 87 million to RMB 320 million. In 2025 the company also claimed to have achieved "nine consecutive years of growth" since 2017. This shows the company is not a stage-specific story suddenly stacked up by one or two boom years.
Second, cash-flow quality is clearly better than that of many peer growth stocks. Over the three years 2023-2025, net operating cash flow was RMB 529 million, 627 million, and 733 million respectively, all substantially higher than the net profit of the period. In other words, the company is not the typical "paper profit, empty pocket" case. In 2025 net cash flow from operating activities grew 16.76% year-on-year to RMB 733 million, and although it declined year-on-year in the first quarter of 2026 it remained positive at RMB 100 million. From an owner's perspective, this is a more important fact than merely looking at PE.
Third, growth is not costless. In 2022 the company's capex reached RMB 534 million, far higher than that year's operating cash flow of RMB 229 million, and free cash flow was significantly pressured; although capex later returned to the RMB 170-202 million range in 2023-2024 and free cash flow clearly recovered, this still reminds us: Nata Opto-electronic is not the kind of "money-printing machine" that needs almost no further investment. Its growth is inseparable from R&D, process, and new capacity, especially in businesses such as photoresist and advanced precursors.
Profit Quality and Balance Sheet
The 2025 financial statement report shows that in 2025 the company had operating profit of RMB 471 million, total profit of RMB 469 million, and net profit attributable to the parent of RMB 320 million. In the same year, other income was RMB 119 million and investment income was RMB 59.5 million, while asset-impairment losses reached RMB 160 million. There is an important quality judgment here: the company's profit is not driven purely by core-business gross margin—it does contain a certain component of subsidies / wealth-management / equity-method income; but on the other hand, the company did not window-dress by "under-provisioning", and instead recognized the sizable impairment loss in the current period. The gap between net profit and net profit excluding non-recurring items is about RMB 66.2 million, showing that profit quality is acceptable, but it cannot be treated as "completely pure" high-quality cash-cow profit.
From the balance sheet, at the end of 2025 the company had total assets of RMB 6.157 billion and total liabilities of RMB 2.175 billion, an asset-liability ratio of about 35.3%; by the first quarter of 2026, cash was RMB 522 million and trading financial assets were RMB 1.372 billion, while interest-bearing debt roughly included short-term borrowings of RMB 13.14 million, non-current liabilities due within one year of RMB 17.58 million, and long-term borrowings of RMB 70 million. This means the company is in a clear net-cash position rather than a leverage-driven company. For long-term investors, this greatly reduces the risk of "permanent loss due to a broken financing chain".
That said, working capital also has points worth watching. At the end of 2025 the company's accounts receivable were RMB 698 million, up 18.45% year-on-year, and inventory was RMB 843 million, up 16.66% year-on-year; by the first quarter of 2026, accounts receivable rose further to RMB 768 million, and inventory was still RMB 811 million. This does not automatically constitute a risk, but it shows the company still needs capital tie-up during expansion, and materials companies may see inventory and receivables compress cash-conversion efficiency during new-product ramps, price volatility, or downstream destocking.
On interest coverage, in 2025 interest expense was about RMB 28.47 million and operating profit was about RMB 471 million, so roughly operating profit / interest expense is about 16.5x, indicating little debt-service pressure. Net debt / EBITDA is essentially negative because the company is in a net-cash position. Placed among A-share semiconductor-materials companies, this kind of balance sheet is on the more robust side.
On accounting risk, I have not seen direct evidence of fraud. The unqualified audit opinion, the internal-control evaluation with no material weakness, and the fact that the company did not gloss over impairments and project terminations are all positive signals. What truly needs to be worried about is not "a sudden explosive fraud", but high valuation compounded by growth falling short of expectations, which is more likely to cause poor long-term returns than accounting problems.
Owner Earnings Estimate
Definition and caliber The simplified caliber of Buffett-style Owner Earnings is usually: operating cash flow – maintenance capex. Because the full original figure for "cash paid to acquire fixed assets, intangible assets, and other long-term assets" in the body of the full-year 2025 audit report was not directly obtained this time, I take a conservative but transparent approach: based on the realized capex of RMB 170-202 million in 2023-2024, and considering the 2025 transfer of construction-in-progress to fixed assets, the continued R&D investment in photoresist and precursors, and operating-maintenance needs, I assume 2025 maintenance capex of about RMB 210-230 million. This is obviously not a precise figure, but for conservative investors it is more prudent than treating all operating cash flow as free cash.
Under this assumption, 2025 Owner Earnings is roughly:
Net operating cash flow: RMB 733 million
Less: maintenance capex: RMB 210-230 million
Equals: Owner Earnings: about RMB 500-520 million
If I also apply a small conservative discount to the relatively strong 2025 working-capital release, I would prefer to place the sustainable Owner Earnings center of gravity at RMB 480-500 million. This is higher than the 2025 net profit of RMB 320 million, showing that the company's real cash-generating power is better than its accounting profit; but note that it contains some wealth-management income and interest-income impact, so it cannot be simply understood as "the pure core operating profit has already reached RMB 500 million".
Based on the approximate current price of RMB 56 per share adopted in this report and total share capital of 691 million shares, the market cap is about RMB 38.7 billion. Using an Owner Earnings center of gravity of RMB 480-500 million, the current price is equivalent to about 77-81x Owner Earnings. For an industrial-materials business that has not yet formed an extremely wide moat and where some businesses' gross margins are still pressured, this multiple is clearly on the high side.
Valuation, Margin of Safety, and Alternatives
Intrinsic Value Estimate
Owner Earnings Discount Method
I use three scenarios for a simplified DCF. The key here is not "precision to two decimal places" but seeing what kind of operating results the company must achieve for RMB 56 per share to be reasonable today.
Assumptions
| Scenario | Starting Owner Earnings | First-5-year growth | Next-5-year growth | Discount rate | Perpetual growth |
|---|---|---|---|---|---|
| Conservative | RMB 480 million | 5% | 3% | 12% | 2% |
| Neutral | RMB 500 million | 10% | 5% | 11% | 3% |
| Optimistic | RMB 520 million | 15% | 7% | 10% | 4% |
Under these assumptions, the rough per-share intrinsic values I obtain are:
Conservative scenario: about RMB 8-11 per share
Neutral scenario: about RMB 13-16 per share
Optimistic scenario: about RMB 23-26 per share
Considering the company's net cash, the option value of ArF photoresist, and the strategic premium the market grants for domestic substitution, I am willing to add some "real-world" flexibility on top of the DCF results, so my final range will be slightly higher than the pure mathematical DCF, but not so high as to approach the current stock price. The core conclusion here is simple: the current stock price demands that the company deliver very high-quality, sustained, and error-free growth over the next decade, and this is not odds that a conservative investor should actively bet on.
Relative Valuation Method
Relative valuation cannot prove it is cheap, but it can prove it is not cheap.
| Company | Approximate valuation info | Assessment |
|---|---|---|
| Nata Opto-electronic | Current price about RMB 56; static PE about 121x; PB about 11.1x; 2025 ROE 9.19% | High valuation, high expectations |
| Yoke Technology | PE about 54.8x; PB about 6.8x | Larger in scale, yet lower valuation |
| Huate Gas | PB about 12.25x; EV/recurring profit about 197-209x; ROIC/ROE about 5.8%-6.2% | The industry as a whole is on the pricey side, but this does not prove Nata Opto-electronic is cheap |
| Jingrui Electronic Materials | PB about 6.39x; EV/recurring profit about 345.6x; ROIC about 4.6% | Low return rate, valuation not low either |
| Tongcheng New Materials | PE about 66.26x; PB about 8.56x; EV/recurring profit about 74.9x | Quality assets in the industry are also expensive, but Nata Opto-electronic shows no clear valuation advantage |
Nata Opto-electronic's own PE and PB are both higher than most comparables; there is at least no value-type opportunity of "peers are worse, it is cheaper". In particular Yoke Technology, as a stronger, larger, and more mature platform-type electronic-materials company, is currently valued no more expensively than Nata Opto-electronic—a direct counter-argument to whether it is "worth tying up my capital".
Asset Value Method
Viewed from an asset or liquidation angle, Nata Opto-electronic's protection is not strong. At the end of 2025 the company's net assets attributable to the parent were about RMB 3.482 billion, while the current approximate market cap is about RMB 38.7 billion; in the first quarter of 2026 the company's cash plus trading financial assets were about RMB 1.894 billion, and even adding some other financial assets, this comes nowhere near supporting the current market cap. In other words, when you buy this stock, the vast majority of what you buy is not existing assets but the delivery of many years of future growth and the maintenance of a high valuation. This kind of stock is spectacular when growth is delivered, but once delivery is slower than expected, permanent capital loss usually comes from valuation compression rather than corporate bankruptcy.
Final Valuation Range and Margin of Safety
Combining the three methods above, the range I give is as follows:
| Range | Valuation judgment |
|---|---|
| Conservative intrinsic-value range | RMB 11-15 per share |
| Fair intrinsic-value range | RMB 16-25 per share |
| Optimistic intrinsic-value range | RMB 25-35 per share |
Based on the current approximate price of about RMB 56 per share:
Relative to the fair intrinsic-value range, the current price carries roughly a 124%-250% premium;
Relative to the optimistic intrinsic-value range, there is still a premium of about 60% or more.
Therefore, the current price has no margin of safety. If two things happen simultaneously in the future—ArF photoresist revenue truly moving from "tens-of-millions level" to "hundred-million level", and electronic specialty gas and precursor margins holding or improving—my valuation ceiling would rise; but before these facts land, today's price clearly runs ahead of the fundamentals.
For conservative long-term investors, I believe:
Ideal buy-price range: RMB 15-20 per share
Acceptable holding-price range: RMB 20-28 per share
Clearly overvalued price range: above RMB 35 per share
Current price: far above the clearly overvalued range
This may sound harsh, but the core of value investing is not "arguing with the market about how high it can rise" but "at what price I am willing to lock in all my capital for ten years". By this standard, I would not act around RMB 56.
Comparison with Other Opportunities
Compared with broad-based indices, Nata Opto-electronic's valuation does not stand out. The CSI 300's current PE is about 14.61x and PB about 1.42x; the Hang Seng Index PE is about 12.31x; the S&P 500's forward PE is about 21x. Even treating Nata Opto-electronic as a growth stock, its current static PE of about 121x is clearly higher than these broad-based indices. For a balanced-to-conservative investor, unless one can confirm it will significantly outperform the indices, there is no reason to bear the higher risk of valuation drawdown.
Compared with the risk-free rate, China's current 10-year government bond yield is about 1.74%-1.75%. Of course, equity investment should earn more than government bonds; but the problem is that Nata Opto-electronic's current valuation is too high, so the potential annualized return over the next decade may not be significantly higher than government bonds plus a reasonable risk premium. If my neutral operating scenario holds, buying at the current price is more likely to deliver a low-single-digit or even negative annualized return rather than the double-digit return a growth stock should offer.
If I could only hold five assets, I would not put it in the portfolio. The reason is not that it is bad, but that the opportunity cost is higher: within the same track there are companies with cheaper valuations, larger scale, and clearer paths; across tracks, broad-based indices offer a more balanced odds/win-rate ratio. For a long-term owner, capital is a scarce resource and should not overpay for "a popular company within a good industry".
Risks, Checklist, and Final Verdict
Risks and Counterarguments
The strongest counterargument is actually quite forceful: you may be overestimating how quickly the "domestic-substitution narrative" translates into shareholder returns. Nata Opto-electronic is of course on a good track and does have technical and validation progress; but ArF photoresist revenue in 2025 is still only on the order of just over RMB 20 million, far from becoming a profit pillar for the company. At the same time, the electronic specialty gas segment's gross margin has already shown clear pressure, indicating that even with demand growth, not all of it will settle into high-quality profit. If over the next 3-5 years the company's main growth still relies on precursors and specialty gases while photoresist ramp is slower than the market expects, the current valuation will be very fragile.
The risk most in need of guarding against is not short-term volatility but permanent capital loss. I believe it mainly comes from the following categories:
| Risk type | Specific manifestation |
|---|---|
| Competition risk | Specialty gas price competition, peer capacity expansion, and slower customer onboarding drive gross margins further down |
| Technology substitution risk | High-end materials iterate fast; if next-generation product validation lags, the existing layout may be marginalized |
| Commercialization risk | Passing ArF photoresist validation does not equal large-scale ramp; revenue scale and customer penetration may fall below market expectations |
| Valuation risk | The current valuation is already high; if market risk appetite falls, multiple compression can occur even if profit keeps growing |
| Capital-allocation risk | If subsidiary minority-stake acquisitions and project investments return less than expected, goodwill / asset impairment will form |
| Supply-chain and policy risk | Changes in key raw materials, equipment, certification processes, export restrictions, and domestic industrial policy can all affect the pace |
| Accounting-quality risk | The share of non-recurring gains, subsidies, and wealth-management income must be tracked continuously; one cannot look only at book net profit |
Why might this investment be wrong? Because the market may currently be pricing in a "perfect path": precursors keep growing fast, specialty gas margins hold, ArF jumps rapidly from tens-of-millions to hundred-million level, industry prosperity does not fade, and valuation does not compress. If any one condition fails, investment returns may fall short. The worst case is not that the company posts losses and washes out, but that after profit growth slows, the market re-rates it from a "high-growth technology-materials stock" to a "medium-quality semiconductor-materials manufacturer", compressing PE from above 100x to 40-60x; by then, even if the company is still making money, shareholders may suffer a loss of 40%-60% or even more. This scenario is not uncommon among high-valuation growth stocks.
Once the following facts appear, I would consider the investment logic clearly weakened or even overturned:
ArF photoresist stays at the "pilot / tens-of-millions revenue" stage for 2-3 consecutive years, with no visible path to hundred-million-level ramp.
A sustained price war emerges in the precursor or specialty gas segment, driving the overall gross margin down another step.
Operating cash flow weakens over the long term, returning to a state of "profit growing but cash flow not keeping up".
Another large-scale project impairment or a failure to deliver on post-acquisition performance occurs.
Management begins to substitute a stock-price story for operating facts, with markedly less discussion of risk.
Investment Checklist
| Checklist | Assessment |
|---|---|
| Can I understand this business | Pass |
| Does it have stable long-term demand | Pass |
| Does it have a durable moat | Not fully pass |
| Does it have pricing power | Fail |
| Can it generate stable free cash flow | Uncertain |
| Is its return on capital excellent | Uncertain |
| Is management trustworthy | Pass |
| Is capital allocation rational | Uncertain |
| Is the balance sheet robust | Pass |
| Is the valuation below intrinsic value | Fail |
| Is the margin of safety sufficient | Fail |
| Does long-term holding let me sleep well | Fail |
| What key facts would make me sell | Photoresist ramp stalling, gross margins declining continuously, operating cash flow weakening, another large impairment |
| Am I wanting to buy only because of the rising price or market sentiment | If I bought today, most likely yes |
Final Investment Conclusion
【Final Rating】 Watch
【One-Sentence Investment Thesis】 Nata Opto-electronic is a semiconductor key-materials company worth studying, but the current stock price looks more like buying a distant dream than buying real cash flow with a margin of safety.
【Core Bull Case】
The company has genuine technical accumulation in advanced precursors / MO sources, and it is officially confirmed as one of the world's major MO source manufacturers.
Over the past few years, revenue, profit, and operating cash flow have grown continuously, with cash-flow quality clearly stronger than accounting profit.
The balance sheet is robust, with clear net cash and low leverage, and relatively good financial safety.
ArF photoresist has moved from R&D to the customer-validation + orders stage, with long-term option value.
The company has begun to raise dividends, with management showing at least some awareness of shareholder returns.
【Core Bear Case】
The current valuation is too high; based on the approximate current price, the static PE is about 121x and PB about 11x, so a margin of safety essentially does not exist.
The electronic specialty gas segment's gross margin has fallen fairly clearly, showing that pricing power is not solid.
Photoresist is still a "small business"; in 2025 ArF revenue only exceeded RMB 20 million, a vast gap from what the market imagines.
Profit still contains a certain component of other income and investment income, not all from core operations.
Cheaper alternatives are not scarce, such as Yoke Technology.
【Key Assumptions】 For the investment to hold, at minimum it requires: the company's precursors keep growing; electronic specialty gas gross margins stop deteriorating; ArF photoresist revenue reaches hundred-million level over the next 3-5 years; operating cash flow stays above net profit; and the market remains willing to grant a valuation premium to high-growth materials stocks over the long term.
【Fair Buy Price】 The price range I am willing to seriously consider is RMB 15-20 per share. The basis is: after combining Owner Earnings discounting, peer comparison, net cash, and option value, only this range begins to approach the odds where "even if growth falls below expectations, the permanent capital loss will not be too large".
【Target Holding Period】 If entered at a more reasonable price in the future, it is suitable to hold for at least 5-10 years; but the premise is that the purchase price is reasonable, and one must continuously track product validation and profit quality.
【Expected Annualized Return】 This is a rough estimate based on the assumptions in this report, not a promise:
Conservative scenario: -11% to -8%
Neutral scenario: -6% to -3%
Optimistic scenario: 0% to 4% These returns are low not because I am bearish on the company's operations, but because I believe the current price has already priced in a great deal of future success.
【Maximum Loss Risk】 If the company operates roughly normally but photoresist ramp falls short and the valuation retreats to a more ordinary growth-stock range, the stock price faces a downside revision of 40%-60% or even more. If an industry downturn is compounded by margin decline, the loss could widen further.
【Tracking Metrics】 What should be watched most in the future is not the stock price but the following operating facts:
Whether ArF photoresist annual revenue moves from tens-of-millions to hundred-million level.
The revenue growth and gross-margin changes of precursors and electronic specialty gases.
Whether net operating cash flow stays continuously above net profit.
Whether accounts-receivable and inventory turnover deteriorate.
R&D investment intensity and the conversion of R&D results.
Whether large asset impairments recur.
The return delivery after subsidiary minority-stake acquisitions.
Whether the dividend policy remains stable and sustained.
The capacity-expansion and pricing strategies of major industry competitors.
Whether management continues to candidly disclose risks and failed projects.
【Signals Triggering Re-evaluation】
ArF photoresist sees large-scale ramp from leading customers, with revenue and profit beginning to contribute substantially.
Electronic specialty gas gross margins stabilize and recover.
The company maintains high-quality free cash flow for two to three consecutive years.
The valuation retreats sharply, approaching or entering the fair range.
Conversely, if sustained impairments, deteriorating cash flow, and intensifying competition drive overall margins clearly lower, a re-evaluation is also required.
【Final Recommendation】 For a balanced-to-conservative long-term investor, I do not recommend chasing Nata Opto-electronic at the current price. The truly rational approach is to place it on a high-quality watchlist: keep tracking ArF photoresist commercialization, precursor and specialty gas margins, and the sustainability of operating cash flow; if the fundamentals keep improving and the price returns to a level with more margin of safety, then consider entering. What is most lacking now is not a story but restraint on price.
This report is based on public information and does not constitute investment advice. Markets carry risk; invest with caution.
Full report
Sign in to read the full report
Sign up free to unlock the full text, the Baillie growth scorecard, and full-text search.
Log in / Sign up free